Searching For Real Value In Market Debris At Hims & Hers Health Inc (NYSE: HIMS)

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Yahoo Finance discussed the stock recently as it posted Hims & Hers to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Stocks Info

As a NYSE listed company, HIMS falls under the Consumer Defensive sector while operating within the Household & Personal Products industry segment. At the end of the last regular session, the stock closed at $9.85 and fluctuated between $9.90 as its day high and $9.39 as its day low. The current market capitalization of Hims & Hers Health Inc is $2.09B. A total of 2.4 million shares were traded on the day, compared to an average of 2.74M shares.

Insider Activity

Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, HIMS has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 74 BUYs and 102 SELLs from insiders. Insiders purchased 3,221,587 shares during that period but sold 12,716,050.

In the most recent transaction, Dudum Andrew sold 15,100 shares of HIMS for 9.01 per share on Jan 29. After the transaction, the Chief Executive Officer now owns 51,653 company shares. In a previous transaction on Jan 26, Dudum Andrew sold 52,940 shares at 9.11 per share. HIMS shares that Chief Executive Officer owns now total 51,653.

Among the insiders who sold shares, Dudum Andrew disposed of 127,688 shares on Jan 25 at a per-share price of $9.08. This resulted in the Chief Executive Officer holding 51,653 shares of HIMS after the transaction. In another insider transaction, Boughton Soleil sold 13,744 shares at $8.80 per share on Jan 02. Company shares held by the Chief Legal Officer now total 154,345.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for HIMS in the last 3 months, the mean price target is $10.45 with high estimates of $15.00 and low estimates of $7.00. In terms of 52-week highs and lows, HIMS has a high of $12.34 and a low of $5.65.

As of this writing, HIMS has an earnings estimate of $Himax Technologies, Inc. per share for the current quarter. EPS was calculated based on a consensus of Hims & Hers Health, Inc. estimates, with a high estimate of $Hingham Institution for Savings per share and a lower estimate of $Direxion Daily S&P 500 High Bet.

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. HIMS’s latest balance sheet shows that the firm has $247.27M in Cash & Short Term Investments as of fiscal 2021. There were $5.48M in debt and $79.22M in liabilities at the time. Its Book Value Per Share was $1.55, while its Total Shareholder’s Equity was $334.62M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for HIMS is Buy with a score of 4.00.

Most Popular

Related Posts